Brandon R. Rigby1,2*- 1Exercise Physiology Laboratory, School of Health Promotion and Kinesiology, Texas Woman's University, Denton, TX, United States
- 2Institute for Women's Health, Texas Woman's University, Denton, TX, United States
Repeated stresses applied to the rider may contribute to the documented physical and psychosocial outcomes from equine-assisted services. In this brief review, a summary of neuroendocrine markers of stress, including immunoglobulin A, serotonin, cortisol, progesterone, and oxytocin, is presented within the context of the physiology of stress modulation. Results are mixed with regard to the effects of these hormones on rider physiology before, during, and after equine-assisted services. However, some results from existing studies are promising with regard to the attenuation of stress. Future research should include a cross-disciplinary approach when conducting well-controlled studies with proper treatment and experimental fidelity, while also considering exogenous and endogenous factors that influence rider physiology.
1 Introduction
Equine-assisted services (EAS) include various services in which the horse and other equines are utilized to benefit individuals (1). These services include therapy, learning, and horsemanship (1). Previous terms used to denote therapy in this unique setting have included equine-assisted therapy and hippotherapy. Learning and horsemanship have been previously referred to as equine-assisted activities or therapeutic horseback riding. However, these latter terms have been recommended to be discontinued in favor of more inclusive language [for a more detailed summary and consensus on current terminology, see (2, 3)].
During EAS, the rhythmic movement of the horse is used as a tool to improve physical, emotional, and mental health in the rider (4). The physical (5) and psychosocial (6) outcomes of EAS in the rider have been summarized previously. While these exogenous effects have been characterized, the endogenous changes that may allow for improvements in overall function during EAS have not been summarized to date. More specifically, these changes include the stress applied to the rider. Stress is defined as the threat, or perceived threat, to an organism's homeostasis (7). Repeated stresses on bodily systems can lead to physiological adaptations and re-establishment of homeostasis, eliciting an improvement in functional capacity and physical function (7, 8). As the rhythmic movement of the horse elicits repeated bodily movements in the rider during EAS, it follows that the physical adaptations [e.g., gross motor function, balance, posture, muscle asymmetry, spasticity; (5)] to EAS occur, in part, due to the application of acute bouts of stress.
In humans, this adaptive stress response is influenced by cellular, molecular, and neuroendocrine factors located in the central nervous system and periphery (7, 9). When in a stressful state, a fast and slow response occurs (10). The fast response is mediated by the sympathoadrenomedullary (SAM) system, which promotes an increase in epinephrine and norepinephrine from the adrenal medulla and an additional increase in norepinephrine from the sympathetic nerves (10, 11). Once released, these hormones initiate the contraction of muscle cells in the vasculature, skeletal muscle, heart, and other organs (12, 13), resulting in increased physiologic responses that include, but are not limited to, vasoconstriction, blood pressure, heart rate, cardiac output, oxygen consumption, thermogenesis, arousal, alertness, and vigilance (10). The slow response is derived form the activation of the hypothalamic-pituitary-adrenal (HPA) axis, a critical structure both centrally and peripherally located to mediate the stress response (7, 10, 14). The activation of the HPA axis causes a release of corticotropin-releasing factor (CRF) from the hypothalamus in the brain (10). Interestingly, equines present with a similar neuroendocrine profile as humans under periods of stress. Both the SAM system and HPA axis also modulate the release of these hormones in equines (15, 16).
Changes in neuroendocrine responses can attenuate stress in humans following animal interaction (17). Other endogenous markers that have been positively affected in the rider following human-animal interaction include serotonin (18), immunoglobulin A (19), and oxytocin (20). In this brief review, a summary of the neuroendocrine markers of stress is presented. Concentration changes before, during, and after EAS are provided. A brief summary of the stress incurred by the equine during EAS is also presented. Finally, future directions for research are discussed.
2 Immunoglobulin A
Immunoglobulin A (IgA) is the most dominant antibody in immunity, regulating mucosal homeostasis (21). Once secreted in the lumen, it binds to antigens and prevents toxins from entering the submucosa and circulation (22). Acting as the primary barrier to pathogens and irritants, increased concentrations may promote immune health (21). As the immune system is integrated with other organs in the body, including the brain, behavior and activity (including tactile contact between mammals) can positively affect immunity (23). Additional lifestyle habits may increase concentrations of IgA, including listening to music (24), relaxing (25), or watching a funny movie (26). Markers of immunity and the associated physiological stress response have remained mostly unexplored in the interaction between humans and equines. However, concentrations of IgA did not change after 15 min of equine-facilitated learning (i.e., moving around a horse while focusing on the response of the horse with awareness of their own bodily sensations) in healthy older adults (27).
3 Serotonin
Serotonin, a neurotransmitter in the central nervous system, is implicated in the function of the cardiovascular, pulmonary, metabolic, gastrointestinal, and genitourinary systems (28). The influence of serotonin on gastrointestinal function and gut microbiome is great, as more than 90% of circulating serotonin in the periphery is synthesized by cells in the gastrointestinal tract (29). Metabolically, it contributes to glucose homeostasis and adiposity, thus influencing the course and progression of chronic diseases (29).
Serotonin receptors are expressed in many regions of the brain, and thus help to regulate the nuclei in these regions involved in behavioral output. In addition to well-known attributes such as mood, sleep and appetite, there are multiple behavioral attributes that are regulated by serotonin, including perception, reward, anger, aggression, memory, and attention (28). More specifically, serotonin may play a key role in emotional regulation and behavioral flexibility, social cognition and control of social interactions, anxiety, and learning and memory (30, 31). The influence of serotonin may therefore be very important to quantify before and after the administration of EAS. There are no known studies that include the measurement of serotonin following an acute or long-term EAS intervention in chronic disease populations. However, serotonin concentrations increased by 5% following 8 weeks of horseback riding in a therapeutic setting in older adults (32).
4 Cortisol
When secreted from the hypothalamus, CRF stimulates the nearby anterior pituitary gland to release adrenocorticotropin (ACTH), eliciting the release of cortisol from the adrenal cortex into the circulation (33). Its metabolic effects include lipolysis, protein catabolism, and an increase in blood glucose by stimulating liver enzymes, although this glucose is blocked when delivered to working tissues (34). However, this mobilization of energy is thought to be the primary function of cortisol during periods of stress (35).
Cortisol responses to EAS have been mixed. Morning salivary cortisol concentrations did not change over the course of 6 weeks of equine therapy in veterans with PTSD (36), or after 10 weeks of therapeutic horseback riding in children with autism spectrum disorder [ASD; (37)]. However, a 20 and 24% decrease in salivary cortisol concentrations were observed after 1 month (38) and 12 weeks (39) of weekly hippotherapy sessions, respectively in male children with ASD. There are positive results reported in healthy populations. Cortisol concentrations decreased by 6% following 8 weeks of horseback riding in a therapeutic setting in older adults (32). In addition, cortisol levels were decreased in these participants when compared to a control group following the riding protocol (32). Finally, 11 weeks of equine-facilitated activities performed once per week, 90 min per session, decreased salivary cortisol concentrations by 20% in healthy adolescents (40). In healthy adults without horseback riding experience, no change in cortisol concentrations was observed in healthy adults following a 2-h horse-riding lesson program (41). However, among healthy adults with horseback riding experience, a 61% and 64% decrease in cortisol concentrations were observed immediately following, and 1 h following, a 2-h horse-riding lesson program, respectively (41). The observed decrease in cortisol concentrations following EAS may be expected, as many of those who participate in these interventions experience relaxing effects during the treatment (42).
5 Progesterone
Traditionally thought of as a female sex hormone, progesterone is produced in the corpus luteum in the ovaries and metabolized primarily in the liver in women (43). In men, progesterone is secreted by the adrenal cortex, and can be metabolized to other sex hormones, including testosterone and estradiol (44). Progesterone also influences mood and behavior via emotion processing (43). Inclusive to emotion processing are emotion recognition accuracy and emotional memories (45). When progesterone concentrations are high, there is a faster response to negative stimuli, which typically presents as a heightened sensitivity to physical threats (46–49). Emotional memories are mediated by the HPA axis, and elevated progesterone levels are correlated with emotional free-recall and recognition memory (50, 51). To date, these phenomena have been only observed in women. However, due to the influence of progesterone on the HPA axis and the brain, the hormone may have positive effects on mood, cognition, and neuronal growth in men and women (52–54).
Acute assessments of progesterone have been completed in male children with ASD after one session of hippotherapy. An increase of 80% in salivary progesterone was observed after 30 min of therapy (38). Longer-term assessments have also been made, with a 21% and an 83% increase in salivary progesterone after 1 month (38) and 12 weeks (39) of weekly hippotherapy sessions, respectively, in the same population. Based on these results, the regulation of mood may be enhanced with EAS in children with ASD due, in part, to the release of progesterone derived from the rider's motivation to bond with the horse (55).
6 Oxytocin
Oxytocin is primarily synthesized in the hypothalamus and released from the pituitary gland (56). Once activated, its presence in the blood affects other organs, including the mammary glands and kidneys (57). Oxytocin may therefore play a crucial role with stress-related behaviors due to its influence within the HPA axis (57). More specifically, the release of oxytocin may elicit decreases in glucocorticoids and concomitant increases in parasympathetic nervous system function, thereby decreasing heart rate and blood pressure (BP) responses (17, 58). Indeed, the active form of oxytocin is related to reduced anxiety and relaxation in children (59). Oxytocin is also implicated in the underlying mechanisms of the development and maintenance of attachment in mammals (60). More specifically, tactile contacts (e.g., touch, warmth, vibration), which are critical for social bonding, may be facilitated by oxytocin (61). The human-animal interaction and, specifically, tactile contact, stimulates the release of salivary, plasma, and urinary oxytocin (62, 63). The validation of salivary oxytocin has recently been shown in mammals (62, 64).
7 Other stress-related measures
Cardiopulmonary measures, including heart rate, BP, pulmonary function, and heart rate variability (HRV), have been characterized as stress-related markers during EAS. Overall, hippotherapy and EAT does not alter heart rate in children with neurologic disorders (65–67) or adults (68), respectively. However, heart rate responses may change based on the level of disability of the rider. Indeed, therapeutic horseback riding may elicit increases in heart rate in children with a moderate to severe pathophysiology (69), particularly when compared to youth with less motor impairment (70). Heart rate responses are lower when riders are grooming and petting horses when compared to walking and leading them (71). A single session of, or training over time involving, EAT or hippotherapy also does not alter BP (65–67, 71) or respiratory responses (67, 69, 71) when assessed after sessions have ended vs. baseline. Fifteen minutes of equine-assisted learning may, however, increase respiratory responses in older adults (27). Finally, based on HRV measures during EAS, there may be an attenuation of sympathetic nervous system activity and an increase in parasympathetic nervous system activity [see (72), for a comprehensive review], thereby resetting balance during periods of perceived stress, and promoting improvements in cognitive and emotional control (73, 74).
8 Considerations of the horse
The stress level of the horse should be considered to ensure the health and welfare of these animals are maintained (75). Because horses are prey animals, they have a heightened awareness to their environment, unlike dogs or cats (36). As such, they are able to perceive, respond, and learn from subtle stimuli in a therapeutic setting (76). Equines can respond to a human presence through changes in the rider's physiology, body language, and vocal tones (76). This response may be accompanied by acute stress in the horse, either from the rider or from another environmental stimuli. Confusion and related conflict behaviors in the horse, when accompanied by stress, can then lead to injury to horse riders and handlers and perpetuate the idea that horses exhibit unpredictable behavior (77). Indeed, if the rider is stressed, this may increase the likelihood of a startled reaction in horses via a transmission of stress, thus increasing the risk of injury (78). Elevated stress levels can elicit negative effects on immunity in horses, which may lead to an increased incidence of colic and gastric ulcers (79–81). Also, strong emotional reactions may impair learning performance in equines (82–84). Taken together, these effects may decrease equine performance and attenuate the benefits received by the rider during EAS.
Although stress responses can be variable, the therapy setting typically does not add stress to the horse. No difference in cortisol concentrations was found between modes of riding [i.e., therapeutic vs. traditional; (85)] or between time points within and across EAS sessions (41, 71). This is significant, as serum-free cortisol concentrations increase within 10 min after exposure to acute stress in equines (86). Furthermore, cortisol, ACTH, and glucose maintained normal ranges over time, and between riders with and without posttraumatic stress disorder (75). Alternatively, a decrease in cortisol levels in the horse by up to 45% may occur when children with psychomotor disabilities participate in EAT (87).
Stress can also be objectively measured in horses using cardiovascular measures, including HRV. Similar to measurements in humans, HRV measures in horses are sensitive and reliable indicators of fear or anxiety (27). Basal HRV variations can be influenced by genotype, behavior, environment, temperament, and dietary habits (88). During a 15-min equine-facilitated learning session with older adults, very low frequency (VLF) ranges of HRV were recorded (27). Power within the VLF band is consistent with improved health (89), with the activity of the parasympathetic nervous system contributing most to VLF power (90). In another study, no changes in HRV were found in horses after several phases and sessions of EAT with riders who had varying health statuses (68, 71, 91). However, HRV measures were different between horses who performed equine-assisted activities and therapies and horses who performed dressage, jumping, and eventing activities (92).
9 Conclusion and future directions
In this review, IgA, serotonin, cortisol, progesterone, and oxytocin were summarized in the context of rider physiology during EAS. Although the characterization of the concentrations of these hormones is mixed throughout the literature, results from existing studies are promising with regard to the attenuation of stress in the rider during EAS. The positive outcomes in stress modulation may contribute to the physical and psychosocial benefits observed across populations of varying age, diagnoses, and horseback riding experience. However, it appears that periods of chronic stress, physiologically manifesting as high concentrations of glucocorticoids and catecholamines, can influence the ability for horses to perform during EAS and can negatively impact the human-animal bond.
Due to the cross-disciplinary nature of this topic, and the difficulty in obtaining and analyzing blood and saliva samples, future research teams should include biologists, biochemists, or some healthcare practitioner (e.g., nurse, phlebotomist, exercise physiologist). More well-controlled studies with proper treatment and experimental fidelity to allow for accurate quantification of stress-related hormone concentrations are needed in this area. A number of physiological factors in the rider should be considered, including method of data collection (salivary vs. plasma and/or serum), time of day (i.e., circadian rhythm), timing of data collection before, during, and after EAS sessions based on knowledge of peak hormone concentrations, and unique sex characteristics (e.g., male vs. female, timing of female menstrual cycle), as any of these can influence neuroendocrine responses to stress (93–95). With these future directions, the next steps can be made in the process of seeking to make EAS more affordable and accessible.
Author contributions
BR: Writing—original draft, Writing—review & editing.
Funding
The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.
Conflict of interest
The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1. PATH International. Optimal Terminology. (2023). Available online at: https://pathintl.org/optimal-terminology/ (accessed September 1, 2023).
2. Fine AH, Andersen SJ. A commentary on the contemporary issues confronting animal assisted and equine assisted interactions. J Equine Vet Sci. (2021) 100:103436. doi: 10.1016/j.jevs.2021.103436
3. Wood W, Alm K, Benjamin J, Thomas L, Andersen D, Pohl L, et al. Optimal terminology for services in the United States that incorporate horses to benefit people: a consensus document. J Altern Complement Med. (2021) 27:88–95. doi: 10.1089/acm.2020.0415
4. PATH International. Therapeutic/Adaptive Horsemanship. (2023). Available online at: https://pathintl.org/programs/therapeutic-adaptive-horsemanship/ (accessed September 1, 2023).
5. Rigby BR, Grandjean PW. The efficacy of equine-assisted activities and therapies on improving physical function. J Altern Complement Med. (2016) 22:9–24. doi: 10.1089/acm.2015.0171
6. Maresca G, Portaro S, Naro A, Crisafulli R, Raffa A, Scarcella I, et al. Hippotherapy in neurodevelopmental disorders: a narrative review focusing on cognitive and behavioral outcomes. Appl Neuropsychol Child. (2022) 11:553–60. doi: 10.1080/21622965.2020.1852084
7. Chrousos GP. Stress and disorders of the stress system. Nat Rev Endocrinol. (2009) 5:374–81. doi: 10.1038/nrendo.2009.106
8. Liguori G. ACSM's Guidelines for Exercise Testing and Prescription. Philadelphia, PA: Wolters Kluwer (2022).
9. Chrousos GP, Gold PW. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA. (1992) 267:1244–52. doi: 10.1001/jama.1992.03480090092034
10. Chu B, Marwaha K, Sanvictores T, Ayers D. Physiology, stress reaction. In: StatPearls. Treasure Island, FL: StatPearls Publishing (2022). Available online at: https://www.ncbi.nlm.nih.gov/books/NBK541120 (accessed September 1, 2023).
11. Agorastos A, Chrousos GP. The neuroendocrinology of stress: the stress-related continuum of chronic disease development. Mol Psychiatry. (2022) 27:502–13. doi: 10.1038/s41380-021-01224-9
12. Burnstock G. Structural and chemical organization of the autonomic nervous system with special reference to non-adrenergic, non-cholinergic transmission. In:Mathias CJ, Bannister R, , editors. Autonomic Failure: A Textbook of Clinical Disorders of the Autonomic Nervous System. Oxford: Oxford University Press (2013). p. 72–82.
13. Tsigos C, Kyrou I, Kassi E, Chrousos GP. Stress: endocrine physiology and pathophysiology. In: Endotext. South Dartmouth, MA: MDText.com, Inc. (2020). Available online at: https://www.ncbi.nlm.nih.gov/books/NBK278995 (accessed September 1, 2023).
14. Tsigos C, Chrousos GP. Physiology of the hypothalamic-pituitary-adrenal axis in health and dysregulation in psychiatric and autoimmune disorders. Endocrinol Metab Clin N Am. (1994) 23:451–66.
15. De Santis M, Contalbrigo L, Borgi M, Cirulli F, Luzi F, Redaelli V, et al. Equine assisted interventions (EAIs): methodological considerations for stress assessment in horses. Vet Sci. (2017) 4:44. doi: 10.3390/vetsci4030044
16. Ferlazzo A, Cravana C, Fazio E, Medica P. The different hormonal system during exercise stress coping in horses. Vet World. (2020) 13:847–59. doi: 10.14202/vetworld.2020.847-859
17. Beetz A, Uvnäs-Moberg K, Julius H, Kotrschal K. Psychosocial and psychophysiological effects of human-animal interactions: the possible role of oxytocin. Front Psychol. (2012) 3:234. doi: 10.3389/fpsyg.2012.00234
18. Menna LF, Santaniello A, Amato A, Ceparano G, Di Maggio A, Sansone M, et al. Changes of oxytocin and serotonin values in dialysis patients after animal assisted activities (AAAs) with a dog – A preliminary study. Animals. (2019) 9:526. doi: 10.3390/ani9080526
19. Krause-Parello CA, Thames M, Ray CM, Kolassa J. Examining the effects of a service-trained facility dog in children undergoing forensic interview for allegations of child sexual abuse. J Child Sex Abus. (2018) 27:305–20. doi: 10.1080/10538712.2018.1443303
20. Kertes DA, Hall N, Bhatt SS. Children's relationship with their pet dogs and OXTR genotype predict child-pet interaction in an experimental setting. Front Psychol. (2018) 9:1472. doi: 10.3389/fpsyg.2018.01472
21. Patel A, Jialal I. Biochemistry, immunoglobulin A. In: StatPearls. Treasure Island, FL: StatPearls Publishing (2023). Available online at: https://www.ncbi.nlm.nih.gov/books/N.B.K.551516 (accessed September 1, 2023).
22. Corthésy B. Role of secretory immunoglobulin A and secretory component in the protection of mucosal surfaces. Fut Microbiol. (2010) 5:817–29. doi: 10.2217/fmb.10.39
23. Zulkifli I. Review of human-animal interactions and their impact on animal productivity and welfare. J Anim Sci Biotechnol. (2013) 4:25. doi: 10.1186/2049-1891-4-25
24. Charnetski CJ, Brennan FX, Harrison JF. Effect of music and auditory stimuli on secretory immunoglobulin A (IgA). Percept Mot Skills. (1998) 87:1163–70. doi: 10.2466/pms.1998.87.3f.1163
25. Green RG, Green ML. Relaxation increases salivary immunoglobulin A. Psychol Rep. (1987) 61:623–9. doi: 10.2466/pr0.1987.61.2.623
26. Dillon KM, Minchoff B, Baker KH. Positive emotional states and enhancement of the immune system. Int J Psychiatry Med. (1985) 15:13–8. doi: 10.2190/R7FD-URN9-PQ7F-A6J7
27. Baldwin AL, Rector BK, Alden AC. Effects of a form of equine-facilitated learning on heart rate variability, immune function, and self-esteem in older adults. People Anim. (2018) 1:5.
28. Berger M, Gray JA, Roth BL. The expanded biology of serotonin. Annu Rev Med. (2009) 60:355–66. doi: 10.1146/annurev.med.60.042307.110802
29. Jones LA, Sun EW, Martin AM, Keating DJ. The ever-changing roles of serotonin. Int J Biochem Cell Biol. (2020) 125:105776. doi: 10.1016/j.biocel.2020.105776
30. Canli T, Lesch K-P. Long story short: the serotonin transporter in emotion regulation and social cognition. Nat Neurosci. (2007) 10:1103–9. doi: 10.1038/nn1964
31. Bacqué-Cazenave J, Bharatiya R, Barrière G, Delbecque J-P, Bouguiyoud N, Di Giovanni G, et al. Serotonin in animal cognition and behavior. Int J Mol Sci. (2020) 21:1649. doi: 10.3390/ijms21051649
32. Cho S-H, Kim J-W, Kim S-R, Cho B-J. Effects of horseback riding exercise therapy on hormone levels in elderly persons. J Phys Ther Sci. (2015) 27:2271–3. doi: 10.1589/jpts.27.2271
33. Brooks GA, Fahey TD, Baldwin KM. Neural-endocrine control of metabolism. In: Exercise Physiology: Human Bioenergetics and Its Applications. New York, NY: McGraw Hill LLC (2005).
34. Powers SK, Howley ET, Quindry J. Cell signaling and the hormonal responses to exercise. In: Exercise Physiology: Theory and Application to Fitness and Performance. New York, NY: McGraw Hill LLC (2021).
35. Covalesky ME, Russoniello CR, Malinowski K. Effects of show-jumping performance stress on plasma heart rate and behavior in horses. J Equine Vet Sci. (1992) 12:244–51. doi: 10.1016/S0737-0806(06)81454-1
36. Burton LE, Qeadan F, Burge MR. Efficacy of equine-assisted psychotherapy in veterans with posttraumatic stress disorder. J Integr Med. (2019) 17:14–9. doi: 10.1016/j.joim.2018.11.001
37. Pan Z, Granger DA, Guérin NA, Shoffner A, Gabriels R. Replication pilot trial of therapeutic horseback riding and cortisol collection with children on the autism spectrum. Front Vet Sci. (2019) 5:312. doi: 10.3389/fvets.2018.00312
38. Tabares C, Vicente F, Sánchez S, Aparicio A, Alejo S, Cubero J. Quantification of hormonal changes by effects of hippotherapy in the autistic population. Neurochem J. (2012) 6:311–6. doi: 10.1134/S1819712412040125
39. Sánchez CT, Castro FV, Herrera SS, Juánez JC. Hormonal changes analysis by effects of horses assisted therapy in the autistic population. Procedia Soc Behav Sci. (2014) 132:87–91. doi: 10.1016/j.sbspro.2014.04.282
40. Pendry P, Smith AN, Roeter SM. Randomized trial examines effects of equine facilitated learning on adolescents' basal cortisol levels. Hum-Anim Interact Bull. (2014) 2:80–95. doi: 10.1079/hai.2014.0003
41. Kang O-D, Yun Y-M. Influence of horse and rider on stress during horse-riding lesson program. Asian-Australas J Anim Sci. (2016) 29:895–900. doi: 10.5713/ajas.15.1068
42. Badin L, Alibran E, Pothier K, Bailly N. Effects of equine-assisted interventions on older adults: a systematic review. Int J Nurs Sci. (2022) 9:542–52. doi: 10.1016/j.ijnss.2022.09.008
43. Sundström-Poromaa I, Comasco E, Sumner R, Luders E. Progesterone – friend or foe? Front. Neuroendocrinol. (2020) 59:100856. doi: 10.1016/j.yfrne.2020.100856
44. Schiffer L, Barnard L, Baranowski ES, Gilligan LC, Taylor AE, Arlt W, et al. Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review. J Steroid Biochem Mol Biol. (2019) 194:105439. doi: 10.1016/j.jsbmb.2019.105439
45. Sundström-Poromaa I. The menstrual cycle influences emotion but has limited effect on cognitive function. Vitam Horm. (2018) 107:349–76. doi: 10.1016/bs.vh.2018.01.016
46. Gasbarri A, Pompili A, d'Onofrio A, Cifariello A, Tavares MC, Tomaz C. Working memory for emotional facial expressions: Role of the estrogen in young women. Psychoneuroendocrinology. (2008) 33:964–72. doi: 10.1016/j.psyneuen.2008.04.007
47. Derntl B, Hack RL, Kryspin-Exner I, Habel U. Association of menstrual cycle phase with the core components of empathy. Horm Behav. (2013) 63:97–104. doi: 10.1016/j.yhbeh.2012.10.009
48. Kamboj SK, Krol KM, Curran HV. A specific association between facial disgust recognition and estradiol levels in naturally cycling women. PLoS ONE. (2015) 10:e0122311. doi: 10.1371/journal.pone.0122311
49. Masataka N, Shibasaki M. Premenstrual enhancement of snake detection in visual search in healthy women. Sci Rep. (2012) 2:307. doi: 10.1038/srep00307
50. Ertman N, Andreano JM, Cahill L. Progesterone at encoding predicts subsequent emotional memory. Learn Mem. (2011) 18:759–63. doi: 10.1101/lm.023267.111
51. Ney LJ, Gogos A, Hsu C-MK, Felmingham KL. An alternative theory for hormone effects on sex differences in PTSD: the role of heightened sex hormones during trauma. Psychoneuroendocrinology. (2019) 109:104416. doi: 10.1016/j.psyneuen.2019.104416
52. Rubinow DR, Schmidt PJ. The neuroendocrinology of menstrual cycle mood disorders. Ann N Y Acad Sci. (1995) 771:648–59. doi: 10.1111/j.1749-6632.1995.tb44717.x
53. Leblanc E, Chan B, Nelson HD. Hormone replacement therapy and cognition. In: Systematic Evidence Reviews. Rockville, MD: Agency for Healthcare Research and Quality (US) (2002). Available online at: https://pubmed.ncbi.nlm.nih.gov/20722108 (accessed September 1, 2023).
54. Brinton RD, Thompson RF, Foy MR, Baudry M, Wang J, Finch CE, et al. Progesterone receptors: form and function in brain. Front Neuroendocrinol. (2008) 29:313–39. doi: 10.1016/j.yfrne.2008.02.001
55. Brown SL, Fredrickson BL, Wirth MM, Poulin MJ, Meier EA, Heaphy ED, et al. Social closeness increases salivary progesterone in humans. Horm Behav. (2009) 56:108–11. doi: 10.1016/j.yhbeh.2009.03.022
56. Swaab DF, Pool CW, Nijveldt F. Immunofluorescence of vasopressin and oxytocin in the rat hypothalamo-neurohypophypopseal system. J Neural Transm 36. (1975) 195–215. doi: 10.1007/BF01253126
57. Marazziti D, Dell'osso MC. The role of oxytocin in neuropsychiatric disorders. Curr Med Chem. (2008) 15:698–704. doi: 10.2174/092986708783885291
58. Uvnäs-Moberg K. Oxytocin may mediate the benefits of positive social interaction and emotions. Psychoneuroendocrinology. (1998) 23:819–35. doi: 10.1016/S0306-4530(98)00056-0
59. Carter CS. Sex differences in oxytocin and vasopressin: Implications for autism spectrum disorders? Behav Brain Res. (2007) 176:170–86. doi: 10.1016/j.bbr.2006.08.025
60. Gordon I, Martin C, Feldman R, Leckman JF. Oxytocin and social motivation. Dev Cogn Neurosci. (2011) 1:471–93. doi: 10.1016/j.dcn.2011.07.007
61. Carter CS. Neuroendocrine perspectives on social attachment and love. Psychoneuroendocrinology. (1998) 23:779–818. doi: 10.1016/S0306-4530(98)00055-9
62. Carter CS, Pournajafi-Nazarloo H, Kramer KM, Ziegler TE, White-Traut R, Bello D, et al. Oxytocin: behavioral associations and potential as a salivary biomarker. Ann N Y Acad Sci. (2007) 1098:312–22. doi: 10.1196/annals.1384.006
63. Brandtzaeg OK, Johnsen E, Roberg-Larsen H, Seip KF, MacLean EL, Gesquiere LR, et al. Proteomics tools reveal startlingly high amounts of oxytocin in plasma and serum. Sci Rep. (2016) 6:31693. doi: 10.1038/srep31693
64. MacLean EL, Gesquiere LR, Gee N, Levy K, Martin WL, Carter CS. Validation of salivary oxytocin and vasopressin as biomarkers in domestic dogs. J Neurosci Methods. (2018) 293:67–76. doi: 10.1016/j.jneumeth.2017.08.033
65. Yokoyama M, Kaname T, Tabata M, Hotta K, Shimizu R, Kamiya K, et al. Hippotherapy to improve hypertonia caused by autonomic imbalance in children with spastic cerebral palsy. Kitasato Med J. (2013) 43:67–73.
66. Rigby BR, Gloeckner AR, Sessums S, Lanning BA, Grandjean PW. Changes in cardiorespiratory responses and kinematics with hippotherapy in youth with and without cerebral palsy. Res Q Exerc Sport. (2017) 88:26–35. doi: 10.1080/02701367.2016.1266458
67. Cabiddu R, Borghi-Silva A, Trimer R, Trimer V, Ricci PA, Monteiro CI, et al. Hippotherapy acute impact on heart rate variability non-linear dynamics in neurological disorders. Physiol Behav. (2016) 159:88–94. doi: 10.1016/j.physbeh.2016.03.012
68. Mendonça T, Bienboire-Frosini C, Menuge F, Leclercq J, Lafont-Lecuelle C, Arroub S, et al. The impact of equine-assisted therapy on equine behavioral and physiological responses. Animals. (2019) 9:409. doi: 10.3390/ani9070409
69. Bongers BC, Takken T. Physiological demands of therapeutic horseback riding in children with moderate to severe motor impairments: an exploratory study. Pediatr Phys Ther. (2012) 24:252–7. doi: 10.1097/PEP.0b013e31825c1a7d
70. Dirienzo LN, Dirienzo LT, Baceski DA. Heart rate response to therapeutic riding in children with cerebral palsy: an exploratory study. Pediatr Phys Ther. (2007) 19:160–5. doi: 10.1097/PEP.0b013e31804a57a8
71. Malinowski K, Yee C, Tevlin JM, Birks EK, Durando MM, Pournajafi-Nazarloo H, et al. The effects of equine assisted therapy on plasma cortisol and oxytocin concentrations and heart rate variability in horses and measures of symptoms of post-traumatic stress disorder in veterans. J Equine Vet Sci. (2018) 64:17–26. doi: 10.1016/j.jevs.2018.01.011
72. García-Gómez A, Guerrero-Barona E, García-Peña I, Rodríguez-Jiménez M, Moreno-Manso JM. Equine-assisted therapeutic activities and their influence on the heart rate variability: a systematic review. Complement Ther Clin Pract. (2020) 39:101167. doi: 10.1016/j.ctcp.2020.101167
73. Porges SW. The polyvagal perspective. Biol Psychol. (2007) 74:116–43. doi: 10.1016/j.biopsycho.2006.06.009
74. Thayer JF, Ahs F, Fredrikson M, Sollers JJ, Wager TD. A meta-analysis of heart rate variability and neuroimaging studies: Implications for heart rate variability as a marker of stress and health. Neurosci Biobehav Rev. (2012) 36:747–56. doi: 10.1016/j.neubiorev.2011.11.009
75. Johnson RA, Johnson PJ, Megarani DV, Patel SD, Yaglom HD, Osterlind S, et al. Horses working in therapeutic riding programs: Cortisol, adrenocorticotropic hormone, glucose, and behavior stress indicators. J Equine Vet Sci. (2017) 57:77–85. doi: 10.1016/j.jevs.2017.05.006
76. PATH International. Learn About EAAT. (2023). Available online at: https://old.pathintl.org/resources-education/resources/eaat (accessed September 1, 2023).
77. Merkies K, Sievers A, Zakrajsek E, MacGregor H, Bergeron R, Borstel UK. Preliminary results suggest an influence of psychological and physiological stress in humans on horse heart rate and behavior. J Vet Behav. (2014) 9:242–7. doi: 10.1016/j.jveb.2014.06.003
78. Keeling LJ, Jonare L, Lanneborn L. Investigating horse-human interactions: the effect of a nervous human. Vet J. (2009) 181:70–1. doi: 10.1016/j.tvjl.2009.03.013
79. Furr MO, Murray MJ, Ferguson DC. The effects of stress on gastric ulceration, T3, T4, reverse T3 and cortisol in neonatal foals. Equine Vet J. (1992) 24:37–40. doi: 10.1111/j.2042-3306.1992.tb02776.x
80. Keadle TL, Pourciau SS, Melrose PA, Kammerling SG, Horohov DW. Acute exercises stress modulates immune function in unfit horses. J Equine Vet Sci. (1993) 13:226–31. doi: 10.1016/S0737-0806(06)81019-1
81. Leal BB, Alves GES, Douglas RH, Bringel B, Young RJ, Haddad JPA, et al. Cortisol circadian rhythm ratio: a simple method to detect stressed horses at higher risk of colic? J. Equine Vet Sci. (2011) 31:188–90. doi: 10.1016/j.jevs.2011.02.005
82. Lansade L, Simon F. Horses' learning performances are under the influence of several temperamental dimensions. Appl Anim Behav Sci. (2010) 125:30–7. doi: 10.1016/j.applanim.2010.02.010
83. Lesimple C, Fureix C, LeScolan N, Richard-Yris M-A, Hausberger M. Housing conditions are breed are associated with emotionality and cognitive abilities in riding school horses. Appl Anim Behav Sci. (2011) 129:92–9. doi: 10.1016/j.applanim.2010.11.005
84. Hausberger M, Stomp M, Sankey C, Brajon S, Lunel C, Henry S. Mutual interactions between cognition and welfare: the horse as an animal model. Neurosci Biobehav Rev. (2019) 107:540–59. doi: 10.1016/j.neubiorev.2019.08.022
85. McKinney C, Mueller MK, Frank N. Effects of therapeutic riding on measures of stress in horses. J Equine Vet Sci. (2015) 35:922–8. doi: 10.1016/j.jevs.2015.08.015
86. Peeters M, Sulon J, Beckers J-F, Ledoux D, Vandenheede M. Comparison between blood serum and salivary cortisol concentrations in horses using an adrenocorticotropic hormone challenge. Equine Vet J. (2011) 43:487–93. doi: 10.1111/j.2042-3306.2010.00294.x
87. Fazio E, Medica P, Cravana C, Ferlazzo A. Hypothalamic-pituitary-adrenal axis responses of horses to therapeutic riding program: effects of different riders. Physiol Behav. (2013) 118:138–43. doi: 10.1016/j.physbeh.2013.05.009
88. von Borel E, Langbein J, Després G, Hansen S, Leterrier C, Marchant J, et al. Heart rate variability as a measure of autonomic regulation of cardiac activity for assessing stress and welfare in farm animals – A review. Physiol Behav. (2007) 92:293–316. doi: 10.1016/j.physbeh.2007.01.007
89. Bernardi L, Valle F, Coco M, Calciati A, Sleight P. Physical activity influences heart rate variability and very-low-frequency components in Holter electrocardiograms. Cardiovasc Res. (1996) 32:234–7. doi: 10.1016/0008-6363(96)00081-8
90. Shaffer F, Ginsberg JP. An overview of heart rate variability metrics and norms. Front Public Health. (2017) 5:258. doi: 10.3389/fpubh.2017.00258
91. Gehrke EK, Baldwin A, Schiltz PM. Heart rate variability in horses engaged in equine-assisted activities. J Equine Vet Sci. (2011) 31:78–84. doi: 10.1016/j.jevs.2010.12.007
92. Mendonça T, Bienboire-Frosini C, Kowalczyk I, Leclercq J, Arroub S, Pageat P. Equine activities influence horses' responses to different stimuli: could this have an impact on equine welfare? Animals. (2019) 9:290. doi: 10.3390/ani9060290
93. Gatti R, De Palo EF. An update: salivary hormones and physical exercise. Scand J Med Sci Sports. (2011) 21:157–69. doi: 10.1111/j.1600-0838.2010.01252.x
94. Russell G, Lightman S. The human stress response. Nat Rev Endocrinol. (2019) 15:525–34. doi: 10.1038/s41574-019-0228-0
Keywords: equine-assisted activities and therapies, hippotherapy, horse physiology, neuroendocrine, rider physiology, therapeutic horseback riding
Citation: Rigby BR (2023) Characterizing stress during animal interaction: a focus on the human endocrine response during equine-assisted services. Front. Vet. Sci. 10:1303354. doi: 10.3389/fvets.2023.1303354
Received: 27 September 2023; Accepted: 04 December 2023;
Published: 18 December 2023.
Edited by:
Alexandra Stergiou, University of Ioannina, GreeceReviewed by:
Barbara Collacchi, National Institute of Health (ISS), ItalyCopyright © 2023 Rigby. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Brandon R. Rigby, YnJpZ2J5JiN4MDAwNDA7dHd1LmVkdQ==